SCM
ONC

Segantii Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Segantii Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-45,813
Closed -$12.3M – 674
2021
Q4 		$12.3M Buy
+45,813
New +$15.5M 0.38% 45
2021
Q1 		– Sell
-6,531
Closed -$1.72M – 361
2020
Q4 		$1.72M Buy
+6,531
New +$1.8M 0.08% 72

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Segantii Capital Management's ONC Position: Q1 2022 in Review

Segantii Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 45,813 shares — an estimated $12.3M sold.

Segantii Capital Management first reported a position in ONC in Q4 2020 and held it in 2 quarters. The position peaked at $12.3M in Q4 2021. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • Segantii Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
  • Segantii Capital Management sold 45,813 BeOne Medicines Ltd shares in Q1 2022, an estimated $12.3M.
  • Segantii Capital Management first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 2 quarters.
  • Segantii Capital Management's BeOne Medicines Ltd position peaked at $12.3M in Q4 2021.
  • 239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on Segantii Capital Management's 13F filing for Q1 2022, filed 26 Apr 2022.